skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon



医療用医薬品の開発初期段階のポートフォリオ戦略から、臨床研究開発、商業化計画、市販後調査まで。米国、欧州5か国 、日本の計7つの市場を中心に、医療用医薬品や医療機器の市場調査、世界中の研究開発パイプラインや臨床試験情報のデータベースなどを提供しています。


View Less


Scrip Logo
Pink sheet logo
In Vivo Logo
Medtech Insight Logo
Datamonitor healthcare logo
Pharmaprojects logo
Trialtrove logo
Sitetrove Logo
Meddevicetracker logo
Pharmapremia logo
Pharma Consulting logo


  • 世界の薬事規制動向&情報を配信

    Pink Sheet – US Election and New Administration Coverage

    Stay informed of the latest news from the recent US election and understand how the shift in power will affect pharma regulatory and policy issues both within the United States and abroad. Pink Sheet takes you behind the US election headlines for analysis on the real impact you can expect to see on your business.

    Topic us-election-2020

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価, Scrip: 世界の医療用医薬品&製薬産業に関するニ...

    39th Annual J.P. Morgan Healthcare Conference 2021

    39th Annual J.P. Morgan Healthcare Conference 2021

    Keep up with events as they unfold at the 39th Annual J.P. Morgan Annual Healthcare Conference on January 11-14, 2021. Pharma Intelligence and Insights journalists will bring you real time reporting, highlighting important events and key takeaways from every day of the largest and most informative healthcare investment symposium in the industry.

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート



    Topic Coronavirus vaccines

  • In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース

    Pharma Intelligence Insights – Outlook 2021 Report

    Power your strongest strategy for the year ahead with insights from the Outlook 2021 report. A combination of Scrip’s Scrip 100, Medtech Insight’s Medtech 100, and In Vivo’s Outlook reports, Outlook 2021 is a comprehensive window into the key trends, challenges and opportunities impacting the biopharma, medtech, and generics sectors for the year to come.

    Topic Outlook

  • Pink Sheet: 世界の薬事規制と承認審査に関するニュース

    With US Senate Wins In Georgia, Democrats Gain Path For Rx Price Reform, But It May Be Lower Priority


    Razor-thin majorities in both chambers of Congress mean Democrats can’t enact a bold agenda, and the pandemic and attendant recession mean that the initial legislative focus won’t be on Rx issues.

  • Scrip: 世界の医療用医薬品&製薬産業に関するニュース

    First In World COVID-19 Vaccine For Kids Below 12?

    First In World COVID-19 Vaccine For Kids Below 12?

    Could Serum Institute or Bharat Biotech be the first company to have a COVID-19 vaccine for children under 12 years of age? While Pfizer and Moderna have begun pediatric trials for children 12 years and above, Serum plans to begin testing its indigenous vaccine and Bharat Biotech its Covaxin in children under 12

    Topic Coronavirus

  • Pink Sheet: 世界の薬事規制と承認審査に関するニュース

    UK Vaunts 'New Era' In Drug Approvals


    The UK regulator, the MHRA, has published guidance on its new integrated pathway for innovative drug approvals, which it says is intended to bring together partners including health technology assessment agencies, health care bodies and patient organizations to offer “sustained collaboration” with drug developers.

  • Scrip: 世界の医療用医薬品&製薬産業に関するニュース

    How COVID-19 Defined 2020 For Biopharma


    Development of vaccines usually takes years, but drug makers whittled the process down to a matter of months amid a concerted response to a global health threat.

    Topic Coronavirus

  • Medtech Insight: 世界の医療機器・医療技術の最新情報

    MedTech Summit 2020

    The annual Medtech Summit was held online in 2020, and Medtech Insight was there, reporting on the presentations from more than 100 top medical device, diagnostic, and combination product speakers and 15+ Competent Authority and Notified Body representatives. In all, over 50 hours of live and on-demand sessions with critical information and guidance were presented. 

    Topic Medtech

  • Medtech Insight: 世界の医療機器・医療技術の最新情報

    MedTech Summit 2020

    Medtech Summit Article Pack

    The annual Medtech Summit was held online in 2020, and Medtech Insight was there, reporting on the presentations from more than 100 top medical device, diagnostic, and combination product speakers and 15+ Competent Authority and Notified Body representatives. In all, over 50 hours of live and on-demand sessions with critical information and guidance were presented. 

    Topic Medtech

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート, Biomedtracker: 開発中医...




    Topic Coronavirus Clinical Trials

  • Medtech Insight: 世界の医療機器・医療技術の最新情報, Meddevicetracker: 医療機器の市...

    Meddevicetracker & Medtech Insight Spinal Device Markets

    Discover what’s on the horizon for spinal devices and technology with news, analysis, and data from Medtech Insight and Meddevicetracker. Keep up with the latest developments from the annual NASS meeting and explore extracts from two data-packed recent reports: Spinal Fusion Implanted Instrumentation and Spinal Motion Preservation Devices Market.

  • Citeline, Sitetrove: 治験責任医師と治験施設情報のデータベース, Trialtrove: 医療用医薬...

    Achieve Clinical Trial Success with Sitetrove and Trialtrove

    Achieve Clinical Trial Success with Sitetrove and Trialtrove

    Even one misstep in your clinical trials strategy or execution can cost your company millions. Save time and cost with the trusted source for global investigator and site intelligence and global pharmaceutical clinical trial intelligence by subscribing to Sitetrove and Trialtrove.

    Topic clinical-trials Coronavirus

  • Citeline

    Clinical Trials & the COVID-19 Vaccine

    COVID-19 Pulse report

    Informa Pharma Intelligence’s Pulse Report

    Topic Coronavirus clinical-trials

  • Pink Sheet: 世界の薬事規制と承認審査に関するニュース

    US FDA's COVID Whirlwind: Pfizer Vaccine Adcom Set; Monoclonal EUAs Cleared; Trump Aggrieved

    FDA Miss Deadline

    Warp Speed’s Slaoui predicts vaccinations starting within days of the 10 December advisory committee for Pfizer’s coronavirus vaccine. Regeneron’s monoclonal cocktail follows Lilly’s antibody product with an EUA.

    Topic Coronavirus FDA


trial-trove-pharma intelligence

Trialtrove: 医療用医薬品の臨床試験情報データベース


Key benefits:

  • 専門家による情報精査
  • 世界中の臨床試験情報を網羅
  • 標準治療に関する情報
data-monitor-health-care-pharma intelligence


Datamonitor Healthcare(データモニターヘルスケア)では主要な疾患と医薬品をカバーする市場調査レポートを収載し、定期的に更新しています。市場調査レポート1本単位の購入または疾患単位の購読契約による対象の市場調査レポートすべての閲覧が可能です。新医薬品の市場性の評価や研究開発戦略の立案にご利用ください。

Key benefits:

  • 見識者による
  • 最先端ツールで
  • アナリストに
scrip-pharma intelligence

Scrip: 世界の医療用医薬品&製薬産業に関するニュース


Key benefits:

  • ジャーナリストによる世界の医薬品市場動向
  • 国際競争力を強化する独自のニュースと分析
  • 製薬業界の